The objective of this study is to promote the rational drug use of Thailand. E List, clause 2 for specific patients is added in the National List of Essential Medicines, 2551 B.E. Ten medicines, which require knowledge, specialization in disease or advanced technology, are included in the list. However, it is likely that the prescription of these m

This project aims to propose an additional and unified screening package for the Thai population, building upon that offered already by the UC, which will be useful to allocate resources more efficiently and reduce the inequity gap among the three insurance scheme beneficiary groups.   1. To prioritize diseases  for screening  based on availab

In Chiang Mai province, 19.3% of the population are considered obese. According to the Ninth National Economic and Social Development Plan (2002-2006), if obesity exceeds 10%, it will be a major problem that should be solved urgently. The obese children and adolescents are likely to be the obese adults in the ratio about 1 out of 5 and 3 out of 4 r

The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted

This study aims to determine the cost-effectiveness and cost-utility of medical rehabilitation services for inpatients suffering from a stroke. It will compare the outcome of medical rehabilitation services in terms of functional status and quality of life before and after service providing. Moreover, it will compare cost-effectiveness and cost-uti

This study is the first stage under the project of development and evaluation concerning the effectiveness of measures to prevent self-harm in Thailand. The problem conditions, involved factors, signals prior to self-harm and measures to prevent self-harm in selected province were studied. The study results illustrate the problems of inaccessibili

This study aims to evaluate the cost-utility of the routine offers of HIV counseling and testing in community hospitals compared with the current practice. It analyses this by using the social perspective and the payer prospective. The model-based economic evaluation was use to analyze this. Data about the quality of life of HIV infected patients a

The scientific information to support the causal relationship between input/output and outcome/impact of HIV prevention is inadequate and fragmented. A properly conducted economic evaluation could present reasoned and justifiable arguments as to why more or fewer resources should be directed towards particular HIV prevention interventions. However,

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

A cost-utility analysis was performed to estimate the costs and quality adjusted life year (QALY) of HIV prevention program compared to only existing programs. This analysis focused on both the general population and high risk populations. This study found that the incremental cost effectiveness ratio of HIV vaccination was most sensitive to change